Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors

Mesothelin (MSLN) represents an attractive molecule for targeted cancer therapies. To identify tumors that might benefit from such therapies, tissue microarrays including 15,050 tumors from 122 different tumor types and 76 healthy organs were analyzed for MSLN expression by immunohistochemistry. Six...

Descripción completa

Detalles Bibliográficos
Autores principales: Weidemann, Sören, Gagelmann, Pauline, Gorbokon, Natalia, Lennartz, Maximilian, Menz, Anne, Luebke, Andreas M., Kluth, Martina, Hube-Magg, Claudia, Blessin, Niclas C., Fraune, Christoph, Möller, Katharina, Bernreuther, Christian, Lebok, Patrick, Clauditz, Till S., Jacobsen, Frank, Izbicki, Jakob R., Jansen, Kristina, Sauter, Guido, Uhlig, Ria, Wilczak, Waldemar, Steurer, Stefan, Minner, Sarah, Burandt, Eike, Krech, Rainer H., Dum, David, Krech, Till, Marx, Andreas H., Simon, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067734/
https://www.ncbi.nlm.nih.gov/pubmed/33917081
http://dx.doi.org/10.3390/biomedicines9040397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067734/
https://www.ncbi.nlm.nih.gov/pubmed/33917081
http://dx.doi.org/10.3390/biomedicines9040397

Ejemplares similares